Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oxime Industries is a specialty chemical manufacturing company based in Vadodara, India, that focuses on the production of oxime-based compounds and pharmaceutical intermediates. Established in 2005, the company provides high-purity chemical building blocks such as Acetoxime, Methyl Ethyl Ketoxime (MEKO), and Cyclohexanone Oxime to the global life sciences, agrochemical, and industrial coatings sectors. These chemicals are essential for the synthesis of various active pharmaceutical ingredients (APIs) and other complex organic molecules. Oxime Industries operates as a key supplier and contract manufacturer, leveraging its expertise in large-scale chemical synthesis to serve international markets. The company is recognized for its commitment to quality and its role in supporting the pharmaceutical supply chain through the production of specialized reagents.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OXIME Industries.